Showing 1 - 5 results of 5 for search 'Barbara DeNearing', query time: 0.03s Refine Results
  1. 1
    Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers.

    Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers. by Subhra Chakraborty, Clayton Harro, Barbara DeNearing, Jessica Brubaker, Sean Connor, Nicole Maier, Len Dally, Jorge Flores, A Louis Bourgeois, Richard Walker, David A Sack

    Published 2018-04-01
    Get full text
    Article
  2. 2
    Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score.

    Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score. by Chad K Porter, Amanda Lynen, Mark S Riddle, Kawsar Talaat, David Sack, Ramiro L Gutiérrez, Robin McKenzie, Barbara DeNearing, Brittany Feijoo, Robert W Kaminski, David N Taylor, Beth D Kirkpatrick, A Louis Bourgeois

    Published 2018-01-01
    Get full text
    Article
  3. 3
    Efficacy Evaluation of an Intradermally Delivered Enterotoxigenic <i>Escherichia coli</i> CF Antigen I Fimbrial Tip Adhesin Vaccine Coadministered with Heat-Labile Enterotoxin with LT(R192G) against Experimental Challenge with Enterotoxigenic <i>E. coli</i> H10407 in Healthy Adult Volunteers

    Efficacy Evaluation of an Intradermally Delivered Enterotoxigenic <i>Escherichia coli</i> CF Antigen I Fimbrial Tip Adhesin Vaccine Coadministered with Heat-Labile Enterotoxin with... by Ramiro L. Gutiérrez, Chad K. Porter, Clayton Harro, Kawsar Talaat, Mark S. Riddle, Barbara DeNearing, Jessica Brubaker, Milton Maciel, Renee M. Laird, Steven Poole, Subra Chakraborty, Nicole Maier, David A. Sack, Stephen J. Savarino

    Published 2024-01-01
    Get full text
    Article
  4. 4
    Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection

    Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection by Kawsar R. Talaat, Cristina Alaimo, Patricia Martin, A. Louis Bourgeois, Anita M. Dreyer, Robert W. Kaminski, Chad K. Porter, Subhra Chakraborty, Kristen A. Clarkson, Jessica Brubaker, Daniel Elwood, Rahel Frölich, Barbara DeNearing, Hailey Weerts, Brittany L. Feijoo, Jane Halpern, David Sack, Mark S. Riddle, Veronica Gambillara Fonck

    Published 2021-04-01
    Get full text
    Article
  5. 5
    Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccine

    Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccine by Kristen A. Clarkson, Kawsar R. Talaat, Cristina Alaimo, Patricia Martin, A. Louis Bourgeois, Anita Dreyer, Chad K. Porter, Subhra Chakraborty, Jessica Brubaker, Daniel Elwood, Rahel Frölich, Barbara DeNearing, Hailey P. Weerts, Brittany Feijoo, Jane Halpern, David Sack, Mark S. Riddle, Veronica Gambillara Fonck, Robert W. Kaminski

    Published 2021-04-01
    Get full text
    Article

Search Tools: